Graft SurvivalVeinsSaphenous VeinGraft Occlusion, VascularKidney TransplantationJugular VeinsGraft RejectionSurvival RatePortal VeinTreatment OutcomeCell SurvivalTissue DonorsLiver TransplantationImmunosuppressive AgentsTime FactorsCadaverFemoral VeinRetrospective StudiesVascular PatencyTransplantation, HomologousLiving DonorsVaricose VeinsBlood Vessel ProsthesisPancreas TransplantationSurvival AnalysisCorneal TransplantationHyperplasiaFollow-Up StudiesHeart TransplantationPostoperative ComplicationsKeratoplasty, PenetratingAnastomosis, SurgicalReoperationPulmonary VeinsTissue and Organ ProcurementTransplantsCoronary Artery BypassDisease-Free SurvivalVenae CavaeTunica IntimaTacrolimusHistocompatibility TestingImmunosuppressionSkin TransplantationCyclosporineDelayed Graft FunctionOrgan PreservationCold IschemiaPolytetrafluoroethyleneKaplan-Meier EstimateIslets of Langerhans TransplantationMesenteric VeinsIliac VeinSurvivalTransplantation, HeterotopicMycophenolic AcidPopliteal VeinHepatic VeinsTissue and Organ HarvestingBrain DeathProportional Hazards ModelsTransplantation ToleranceRisk FactorsLegRenal VeinsVascular Surgical ProceduresPrimary Graft DysfunctionFemoral ArteryTransplantation, AutologousVena Cava, InferiorUmbilical VeinsRats, Inbred LewGraft Enhancement, ImmunologicRecurrenceLiver FailureBlood Vessel Prosthesis ImplantationMice, Inbred C57BLConstriction, PathologicPopliteal ArteryProspective StudiesAntilymphocyte SerumDeathUltrasonography, Doppler, DuplexTransplantation ImmunologyKidney Failure, ChronicAzathioprineIschemiaIsoantibodiesModels, AnimalSubclavian VeinSplenic VeinThrombosisPolyethylene TerephthalatesHLA AntigensTransplantation, IsogeneicNeointimaOrgan Preservation SolutionsStentsMultivariate AnalysisMice, Inbred BALB C